SEARCH

SEARCH BY CITATION

References

  • Abdouh M., Albert P. R., Drobetsky E., Filep J. G. and Kouassi E. (2004) 5-HT1A-mediated promotion of mitogen-activated T and B cell survival and proliferation is associated with increased translocation of NF-kappaB to the nucleus. Brain. Behav. Immun. 18, 2434.
  • Aberg M. A., Aberg N. D., Hedbacker H., Oscarsson J. and Eriksson P. S. (2000) Peripheral infusion of IGF-I selectively induces neurogenesis in the adult rat hippocampus. J. Neurosci. 20, 28962903.
  • Aberg M. A., Aberg N. D., Palmer T. D., Alborn A., Carlsson-Skwirut C., Bang P., Rosengren L.E., Olsson T., Cage F. H. and Eriksson P. S. (2003) IGF-1 has a direct proliferative effect in adult hippocampal progenitor cells. Mol. Cell. Neurosci. 24, 2340.
  • Adayev T., El-Sherif Y., Barua M., Penington N. J. and Banerjee P. (1999) Agonist Stimulation of the Serotonin1A Receptor Causes Suppression of Anoxia-Induced Apoptosis via Mitogen-Activated Protein Kinase in Neuronal HN2-5 Cells. J. Neurochem. 72, 14891496.
  • Albert P. R., Sajedi N., Lemonde S. and Ghahremani M. H. (1999) Constitutive G(i2)-dependent activation of adenylyl cyclase type II by the 5-HT1A receptor. Inhibition by anxiolytic partial agonists. J. Biol. Chem. 274, 35 46935 474.
  • Araneda R. and Andrade R. (1991) 5-Hydroxytryptamine2 and 5-hydroxytryptamine1A receptors mediate opposing responses on membrane excitability in rat association cortex. Neuroscience 40, 399412.
  • Baker L. P., Nielsen M. D., Impey S., Metcalf M. A., Poser S. W., Chan G., Obrietan K., Hamblin M. W. and Storm D. R. (1998) Stimulation of type 1 and type 8 Ca2+/calmodulin-sensitive adenylyl cyclases by the Gs-coupled 5-hydroxytryptamine subtype 5-HT7A receptor. J. Biol. Chem. 273, 17 46917 476.
  • Banes A., Florian J. A. and Watts S. W. (1999) Mechanisms of 5-hydroxytryptamine (2A) receptor activation of the mitogen-activated protein kinase pathway in vascular smooth muscle. J. Pharmacol. Exp. Ther. 291, 11791187.
  • Berends A. C., Luiten P. G. and Nyakas C. (2005) A review of the neuroprotective properties of the 5-HT1A receptor agonist repinotan HCl (BAYx3702) in ischemic stroke. CNS Drug Rev. 11, 379402.
  • Blay J. and Hollenberg M. D. (1989) Heterologous regulation of EGF receptor function in cultured aortic smooth muscle cells. Eur. J. Pharmacol. 172, 17.
  • Brunet A., Bonni A., Zigmond M. J., Lin M. Z., Juo P., Hu L. S., Anderson M. J., Arden K. C., Blenis J. and Greenberg M. E. (1999) Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell 96, 857868.
  • Carson M. J., Thomas E. A., Danielson P. E. and Sutcliffe J. G. (1996) The 5-HT5A Serotonin Receptor Is Expressed Predominantly by astrocytes in which it Inhibits cAMP Accumulation: A Mechanism for Neuronal Suppression of Reactive Astrocytes. Glia 17, 317326.
  • Chen B., Dowlatshahi D., MacQueen G. M., Wang J. and Young L. T. (2001) Increased hippocampal BDNF immunoreactivity in subjects treated with antidepressant medication. Biol. Psych. 50, 260265.
  • Chen J., Shen C. and Meller E. (2002) 5-HT1A receptor-mediated regulation of mitogen-activated protein kinase phosphorylation in rat brain. Eur. J. Pharmacol. 452, 155162.
  • Cloëz-Tayarania I., Kayyalib U. S., Fanburgb B. L. and Cavaillon J. M. (2005) 5-HT activates ERK MAP kinase in cultured-human peripheral blood mononuclear cells via 5-HT1A receptors. Life Sci. 76, 429443.
  • La Cour C. M., El Mestikawy S., Hanoun N., Hamon M. and Lanfumey L. (2006) Regional Differences in the Coupling of 5-Hydroxytryptamine-1A Receptors to G Proteins in the Rat Brain. Mol. Pharmacol. 70, 10131021.
  • Cowen D. S., Sowers R. S. and Manning D. R. (1996) Activation of a Mitogen-activated Protein Kinase (ERK2) by the 5-Hydroxytryptamine1A receptor is sensitive not only to inhibitors of phosphatidylinositol 3-kinase, but to an inhibitor of phosphatidylcholine hydrolysis. J. Biol. Chem. 271, 22 29722 300.
  • Cowen D. S., Johnson-Farley N. N. and Travkina T. (2005) 5-HT1A Receptors Couple to Activation of Akt, But Not Extracellular-Regulated Kinase (ERK), in Cultured Hippocampal Neurons. J. Neurochem. 93, 910917.
  • Cross D. A. E., Alessi D. R., Cohen P., Andjelkovich M. and Hemmings B. A. (1995) Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature 378, 785789.
  • Crowder R. J. and Freeman R. S. (1998) Phosphatidylinositol 3-kinase and Akt protein kinase are necessary and sufficient for the survival of nerve growth factor-dependent sympathetic neurons. J. Neurosci. 18, 29332943.
  • Datta S. R., Brunet A. and Greenberg M. E. (1999) Cellular survival: a play in three Akts. Genes Dev. 13, 29052927.
  • De Vivo M. and Maayani S. (1987) Characterization of the 5-hydroxytryptamine-1A receptor-mediated inhibition of forskolin-stimulated adenylate cyclase activity in guinea pig and rat hippocampal membranes. J. Pharmacol. Exp. Ther. 238, 248253.
  • Della Rocca G. J., Mukhin Y. V., Garnovskaya M. N., Daaka Y., Clark G. J., Luttrell L. M., Lefkowitz R. J. and Raymond J. R. (1999) Serotonin 5-HT1A receptor-mediated Erk activation requires calcium/calmodulin-dependent receptor endocytosis. J. Biol. Chem. 274, 47494753.
  • Druse M., Tajuddin N. F., Gillespie R. A. and Le P. (2005) Signaling pathways involved with serotonin1A agonist-mediated neuroprotection against ethanol-induced apoptosis of fetal rhombencephalic neurons. Dev. Brain Res. 159, 1828.
  • Duman R. S., Heninger G. R. and Nestler E. J. (1997) A molecular and cellular theory of depression. Arch. Gen. Psychiatry 54, 597606.
  • Errico H., Crozier R. A., Plummer M. R. and Cowen D. S. (2001) 5-HT7 receptors activate the mitogen activated protein kinase extracellular signal related kinase in cultured rat hippocampal neurons. Neuroscience 102, 361367.
  • Garnovskaya M. N., Van Biesen T., Hawes B., Ramos S. C., Lefkowitz R. J. and Raymond J. R. (1996) Ras-dependent activation of fibroblast mitogen-activated protein kinase by 5-HT1A receptor via a G protein βγ-subunit-initiated pathway. Biochemistry 35, 13 71613 722.
  • Garnovskaya M. N., Mukhin Y. and Raymond J. R. (1998) Rapid activation of sodium-proton exchange and extracellular signal-regulated protein kinase in fibroblasts by G protein-coupled 5-HT1A receptor involves distinct signalling cascades. Biochem. J. 330, 489495.
  • Gooz M., Gooz P., Luttrell L. M. and Raymond J. R. (2006) 5-HT2A receptor induces ERK phosphorylation and proliferation through ADAM-17 tumor necrosis factor-alpha-converting enzyme (TACE) activation and heparin-bound epidermal growth factor-like growth factor (HB-EGF) shedding in mesangial cells. J. Biol. Chem. 281, 21 00421 012.
  • Greene E. L., Houghton O., Collinsworth G., Garnovskaya M. N., Nagai T., Sajjad T., Bheemanathini V., Grewal J. S., Paul R. V. and Raymond J. R. (2000) 5-HT2A receptors stimulate mitogen-activated protein kinase via H2O2 generation in rat renal mesangial cells. Am. J. Physiol. Renal Physiol. 278, F650F658.
  • Hershenson M. B., Chao T.-S. O., Abe M. K., Gomes I., Kelleher M. D., Sloway J. and Rosner M. R. (1995) Histamine antagonizes serotonin and growth factor induced mitogen-activated protein kinase activation in bovine tracheal smooth muscle cells. J. Biol. Chem. 270, 19 90819 913.
  • Hetman M., Kanning K., Cavanaugh J. E. and Xia Z. (1999) Neuroprotection by brain-derived neurotrophic factor is mediated by extracellular signal-regulated kinase and phosphatidylinositol 3-kinase. J. Biol. Chem. 274, 22 56922 580.
  • Hoyer D., Clarke D. E., Fozard J. R., Hartig P. R., Martin G. R., Mylecharane E. J., Saxena P. R. and Humphrey P. P. (1994) International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (Serotonin). Pharmacol. Rev. 46, 157203.
  • Hsiung S., Tamir H., Franke T. F. and Liu K. (2005) Roles of extracellular signal-regulated kinase and Akt signaling in coordinating nuclear transcription factor-κB-dependent cell survival after serotonin 1A receptor activation. J. Neurochem. 95, 16531666.
  • Hsu E. H., Lochan A. C. and Cowen D. S. (2001) Activation of Akt1 by human 5-hydroxytryptamine (serotonin)1B receptors is sensitive to inhibitors of MEK. J. Pharmacol. Exp. Ther. 298, 825832.
  • Humblot N., Esteve L., Burgun C., Aunis D. and Zwiller J. (1997) 5-hydroxytriptamine induces TIS8/egr-1 and c-fos expression in PC12 cells. Involvement of tyrosine protein phosphorylation. Eur. J. Neurosci. 9, 8492.
  • Jacobs B. L., Praag H. and Gage F. H. (2000) Adult brain neurogenesis and psychiatry: a novel theory of depression. Mol. Psych. 5, 262269.
  • Johnson-Farley N. N., Kertesy S. B., Dubyak G. R. and Cowen D. S. (2005) Enhanced activation of neuroprotective Akt and extracellular-regulated kinase (ERK) pathways by simultaneous occupancy of Gq-coupled 5-HT2A receptors and Gs-coupled 5-HT7A receptors in PC12 cells. J. Neurochem. 92, 7282.
  • Johnson-Farley N. N., Travkina T. and Cowen D. S. (2006) Cumulative activation of neuroprotective Akt pathway by brain-derived neurotrophic factor and insulin-like growth factor-1 in cultured hippocampal neurons. J. Pharmacol. Exp. Ther. 316, 10621069.
  • Khawaja X., Xu J., Liang J.-J. and Barrett J. E. (2004) Proteomic analysis of protein changes developing in rat hippocampus after chronic antidepressant treatment: Implications for depressive disorders and future therapies. J. Neurosci. Res. 75, 451460.
  • Kushwaha N. and Albert P. R. (2005) Coupling of 5-HT1A autoreceptors to inhibition of mitogen-activated protein kinase. Eur. J. Neurosci. 21, 721732.
  • Lambert H. W. and Lauder J. M. (1999) Serotonin receptor agonists that increase cyclic AMP positively regulate IGF-I in mouse mandibular mesenchymal cells. Dev. Neurosci. 21, 105112.
  • Lambert H. W., Weiss E. R. and Lauder J. M. (2001) Activation of 5-HT receptors that stimulate the adenylyl cyclase pathway positively regulates IGF-I in cultured craniofacial mesenchymal cells. Dev. Neurosci. 23, 7077.
  • Lauder J. M. (1993) Neurotransmitters as growth regulatory signals: role of receptors and second messengers. Trends Neurosci. 16, 233240.
  • Launay J. M., Birraux G., Bondoux D., Callebert J., Choi D. S., Loric S. and Maroteaux L. (1996) Ras involvement in signal transduction by the serotonin 5-HT2B receptor. J. Biol. Chem. 271, 31413147.
  • Lee H. J., Ban J. Y. and Seong Y. H. (2005) Blockade of 5-HT(3) receptor with MDL7222 and Y25130 reduces hydrogen peroxide-induced neurotoxicity in cultured rat cortical cells. Life Sci. 78, 294300.
  • Lenglet S., Louiset E., Delarue C., Vaudry H. and Contesse V. (2002) Activation of 5-HT7 receptor in rat glomerulosa cells is associated with an increase in adenylyl cyclase activity and calcium influx through T-type calcium channels. Endocrinol. 143, 17481760.
  • Li X., Zhu W., Roh M.-S., Friedman A. B., Rosborough K. and Jope R. S. (2004) In vivo regulation of glycogen synthase kinase-3β (GSK3β) by serotonergic activity in mouse brain. Neuropsychopharmacology 29, 14261431.
  • Lin S. L., Setya S. and Cowen D. S. (2002) Differential coupling of 5-HT1 receptors to G proteins of the Gi family. Br. J. Pharmacol. 136, 17021708.
  • Lin S. L., Johnson-Farley N. N., Lubinsky D. R. and Cowen D. S. (2003) Coupling of neuronal 5-HT7 receptors to activation of extracellular-regulated kinase through a protein kinase A-independent pathway that can utilize Epac. J. Neurochem. 87, 10761085.
  • Lione A., Errico M., Lin S. L. and Cowen D. S. (2000) Activation of extracellular signal-regulated kinase (ERK) and Akt by human serotonin 5-HT1B receptors in transfected BE(2)-C neuroblastoma cells is inhibited by RGS4. J. Neurochem. 75, 934938.
  • Liu Y. and Fanburg B. L. (2006) Serotonin-induced growth of pulmonary artery smooth muscle requires activation of phosphatidylinositol 3-kinase/serine-threonine protein kinase B/mammalian target of rapamycin/p70 ribosomal S6 kinase 1. Am. J. Resp. Cell Mol. Biol. 34, 182191.
  • Liu J. and Lauder J. M. (1992) Serotonin promotes region-specific glial influences on cultured serotonin and dopamine neurons. Glia 5, 306317.
  • Madhavan L., Freed W. J., Anantharam V. and Kanthasamy A. G. (2003) 5-hydroxytryptamine 1A receptor activation protects against N-methyl-d-aspartate-induced apoptotic cell death in striatal and mesencephalic cultures. J. Pharmacol. Exp. Ther. 304, 913923.
  • Malberg J. E., Eisch A. J., Nestler E. J. and Duman R. S. (2000) Chronic antidepressant treatment increases neurogenesis in adult hippocampus. J. Neurosci. 20, 91049110.
  • Mallei A., Shi B. and Mocchetti I. (2002) Antidepressant treatments induce the expression of basic fibroblast growth factor in cortical and hippocampal neurons. Mol. Pharmacol. 61, 10171024.
  • Maragnoli M. E., Fumagalli F., Gennarelli M., Racagni G. and Riva M. A. (2004) Fluoxetine and olanzapine have synergistic effects in the modulation of fibroblast growth factor 2 expression within the rat brain. Biol. Psych. 55, 10951102.
  • Markstein R., Hoyer D. and Engel G. (1986) 5-HT1A-receptors mediate stimulation of adenylyl cyclase in rat hippocampus. Naun-Schmiedeberg’s Arch. Pharmacol. 333, 335341.
  • Matsuzaki H., Tamatani M., Mitsuda N., Namikawa K., Kiyama H., Miyake S. and Tohyama M. (1999) Activation of Akt kinase inhibits apoptosis and changes in Bcl-2 and Bax expression induced by nitric oxide in primary hippocampal neurons. J. Neurochem. 73, 20372046.
  • Mendez J., Kadia T. M., Somayazula R. K., El-Badawi K. I. and Cowen D. S. (1999) Differential coupling of 5-HT1A and 5-HT1B receptors to activation of ERK2 and inhibition of adenylyl cyclase. J. Neurochem. 73, 162168.
  • Millan M. J., Newman-Tancredi A., Duqueyroix D. and Cussac D. (2001) Agonist properties of pindolol at h5-HT1A receptors coupled to mitogen-activated protein kinase. Eur. J. Pharmacol. 424, 1317.
  • Nakata N., Suda H., Izumi J., Tanaka Y., Ikeda Y., Kato H., Itoyama Y. and Kogure K. (1997) Role of hippocampal serotonergic neurons in ischemic neuronal death. Behav. Brain Res. 83, 217220.
  • Nebigil C. G., Launay J., Hickel P., Tournois C. and Maroteaux L. (2000) 5-Hydroxytryptamine 2B receptor regulates cell-cycle progression: cross-talk with tyrosine kinase pathways. Proc. Natl Acad. Sci. 97, 25912596.
  • Nebigil C. G., Etienne N., Messaddeq N. and Maroteaux L. (2003) Serotonin is a novel survival factor of cardiomyocytes: mitochondria as a target of 5-HT2B receptor signaling. FASEB J. 17, 13731375.
  • Nibuya M., Nestler E. J. and Duamn R. S. (1996) Chronic antidepressant administration increases the expression of cAMP response element binding protein (CREB) in rat hippocampus. J. Neurosci. 16, 23652372.
  • Nitta A., Zheng W. and Quirion R. (2004) Insulin-like growth factor 1 prevents neuronal cell death induced by corticosterone through activation of the PI3K/Akt pathway. J. Neurosci. Res. 76, 98103.
  • Norum J. H., Hart K. and Levy F. O. (2003) Ras-dependent ERK activation by the human G(s)-coupled serotonin receptors 5-HT4(b) and 5-HT7(a). J. Biol. Chem. 278, 30983104.
  • Norum J. H., Methi T., Mattingly R. R. and Levy F. O. (2004) Endogenous expression and protein kinase A-dependent phosphorylation of the guanine nucleotide exchange factor Ras-GRF1 in human embryonic kidney 293 cells. FEBS J. 272, 23042316.
  • Oosterink B. J., Harkany T. and Luiten P. G. (2003) Post-lesion administration of 5-HT1A receptor agonist 8-OH-DPAT protects cholinergic nucleus basalis neurons against NMDA excitotoxicity. Neuroreport 14, 5760.
  • Pauwels P. J., Wurch T., Palmier C. and Colpaert F. C. (1996) Promotion of cell growth by stimulation of cloned human 5-HT1D receptor sites in transfected C6-glial cells is highly sensitive to intrinsic activity at 5-HT1D receptors. Naunyn Schmiedebergs Arch. Pharmacol. 354, 136144.
  • Pullarkat S. R., Mysels D. J., Tan M. and Cowen D. S. (1998) Coupling of serotonin 5-HT1B receptors to activation of mitogen-activated protein kinase (ERK-2) and p70 S6 kinase signaling systems. J. Neurochem. 71, 10591067.
  • Qiao M., Shapiro P., Kumar R. and Passaniti A. (2004) Insulin-like growth factor-1 regulates endogenous RUNX2 activity in endothelial cells through a phosphatidylinositol 3-kinase/ERK-dependent and Akt-independent signaling pathway. J Biol Chem 279, 42 70942 718.
  • Quinn J. C., Johnson-Farley N. N., Yoon J. Y. and Cowen D. S. (2002) Activation of extracellular-regulated kinase by 5-HT2A receptors in PC12 cells is protein kinase C-independent and requires calmodulin and tyrosine kinases. J. Pharmacol. Exp. Ther. 303, 746752.
  • Radley J. J. and Jacobs B. L. (2002) 5-HT1A receptor antagonist administration decreases cell proliferation in the dentate gyrus. Brain Res. 955, 264267.
  • Santarelli L., Saxe M., Gross C. et al. (2003) Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants. Science 301, 805809.
  • Semkova I., Wolz P. and Krieglestein J. (1998) Neuroprotective effect of 5-HT1A receptor agonist, Bay X 3702, demonstrated in vitro and in vivo. Eur. J. Pharmacol. 359, 251260.
  • Shelton J. G., Steelman L. S., White E. R. and McCubrey J. A. (2004) Synergy between PI3K/Akt and Raf/MEK/ERK pathways in IGF-1R mediated cell cycle progression and prevention of apoptosis in hematopoietic cells. Cell Cycle 3, 372379.
  • Smith M. A., Makino S., Kvetnansky R. and Post R. M. (1995) Stress and glucocorticoids affect the expression of brain-derived neurotrophic factor and neurotrophin-3 mRNAs in the hippocampus. J. Neurosci. 15, 17681777.
  • Sullivan N. R., Crane J. W., Damjanoska K. J., Carrasco G. A., D’Souza D. N., Garcia F. and Van de Kar L. D. (2005) Tandospirone activates neuroendocrine and ERK (MAP kinase) signaling pathways specifically through 5-HT1A receptor mechanisms in vivo. Naunyn-Schmiedebergs Arch. Pharmacol. 371, 1826.
  • Tamatani M., Ogawa S., Niitsu Y. and Tohyama M. (1998) Involvement of Bcl-2 family and caspase-3-like protease in NO-mediated neuronal apoptosis. J. Neurochem. 71, 15881596.
  • Thome J., Sakai N., Shin K.-H., Steffen C., Zhang Y.-J., Impey S., Storm D. and Duman R. S. (2000) cAMP response element-mediated gene transcription is upregulated by chronic antidepressant treatment. J. Neurosci. 20, 40304036.
  • Vaidya V. A., Marek G. J., Aghajanian G. K. and Duman R. S. (1997) 5-HT2A receptor-mediated regulation of brain-derived neurotrophic factor mRNA in the hippocampus and the neocortex. J. Neurosci. 17, 27852795.
  • Vaidya V. A., Terwilliger R. M. and Duman R. S. (1999) Role of 5-HT2A receptors in the stress-induced down-regulation of brain-derived neurotrophic factor expression in rat hippocampus. Neurosci. Lett. 262, 14.
  • Vanhoose A. M., Emery M., Jimenez L. and Winder D.G. (2002) ERK activation by G-protein-coupled receptors in mouse brain is receptor identity-specific. J. Biol. Chem. 277, 90499053.
  • Vicentic A., Li Q., Battaglia G. and Van de Kar L. D. (1998) WAY-100635 inhibits 8-OHDPAT-stimulated oxytocin, ACTH and corticosterone, but not prolactin secretion. Eur. J. Pharmacol. 346, 261266.
  • Watts S. W. (1996) Serotonin activates the mitogen-activated protein kinase kinase pathway in vascular smooth muscle: use of the mitogen-activated protein kinase kinase inhibitor PD098059. J. Pharmacol. Exper. Ther. 279, 15411550.
  • Werry T. D., Gregory K. J., Sexton P. M. and Christopoulos A. (2005) Characterization of serotonin 5-HT2C receptor signaling to extracellular signal-regulated kinases 1 and 2. J. Neurochem. 93, 16031615.
  • Yamada M., Tanabe K., Wada K., Shimoke K., Ishikawa Y., Ikeuchi T., Koizumi S. and Hatanaka H. (2001) Differences in survival-promoting effects and intracellular signaling properties of BDNF and IGF-1 in cultured cerebral cortical neurons. J. Neurochem. 78, 940951.
  • Yamaguchi A., Tamatani M., Matsuzaki H., Namikawa K., Kiyama H., Vitek M. P., Mitsuda N. and Tohyama M. (2001) Akt activation protects hippocampal neurons from apoptosis by inhibiting transcriptional activity of p53. J. Biol. Chem. 276, 52562564.
  • Yao R. and Cooper G. M. (1995) Requirement for phosphatidylinositol-3 kinase in the prevention of apoptosis by nerve growth factor. Science 267, 20032006.
  • Zheng W. and Quirion R. (2004) Comparative signaling pathways of insulin-like growth factor-1 and Brain-derived neurotrophic factor in hippocampal neurons and the role of PI3 kinase pathway in cell survival. J. Neurochem. 89, 844852.